{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T12:04:16Z","timestamp":1785326656579,"version":"3.55.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["AG045335"],"award-info":[{"award-number":["AG045335"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["AG056387"],"award-info":[{"award-number":["AG056387"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["AG057331"],"award-info":[{"award-number":["AG057331"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["AG047797"],"award-info":[{"award-number":["AG047797"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["K01AG061264"],"award-info":[{"award-number":["K01AG061264"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W911NF-12-1-9159"],"award-info":[{"award-number":["W911NF-12-1-9159"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W911F-15-1-0169"],"award-info":[{"award-number":["W911F-15-1-0169"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["HD67244"],"award-info":[{"award-number":["HD67244"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL87062"],"award-info":[{"award-number":["HL87062"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS089076"],"award-info":[{"award-number":["NS089076"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"},{"DOI":"10.13039\/100007625","name":"Cure Alzheimer&apos;s Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The \u03b54 allele of apolipoprotein E (\n                    <jats:italic>APOE<\/jats:italic>\n                    ) is the dominant genetic risk factor for late-onset Alzheimer\u2019s disease (AD). However, the reason for the association between\n                    <jats:italic>APOE4<\/jats:italic>\n                    and AD remains unclear. While much of the research has focused on the ability of the apoE4 protein to increase the aggregation and decrease the clearance of A\u03b2, there is also an abundance of data showing that\n                    <jats:italic>APOE4<\/jats:italic>\n                    negatively impacts many additional processes in the brain, including bioenergetics. In order to gain a more comprehensive understanding of\n                    <jats:italic>APOE4<\/jats:italic>\n                    \u2032s role in AD pathogenesis, we performed a transcriptomics analysis of\n                    <jats:italic>APOE4<\/jats:italic>\n                    vs.\n                    <jats:italic>APOE3<\/jats:italic>\n                    expression in the entorhinal cortex (EC) and primary visual cortex (PVC) of aged\n                    <jats:italic>APOE<\/jats:italic>\n                    mice. This study revealed EC-specific upregulation of genes related to oxidative phosphorylation (OxPhos). Follow-up analysis utilizing the Seahorse platform showed decreased mitochondrial respiration with age in the hippocampus and cortex of\u00a0\n                    <jats:italic>APOE4<\/jats:italic>\n                    vs.\n                    <jats:italic>APOE3<\/jats:italic>\n                    mice, but not in the EC of these mice. Additional studies, as well as the original transcriptomics data, suggest that multiple bioenergetic pathways are differentially regulated by\n                    <jats:italic>APOE4<\/jats:italic>\n                    expression in the EC of aged\n                    <jats:italic>APOE<\/jats:italic>\n                    mice in order to increase the mitochondrial coupling efficiency in this region. Given the importance of the EC as one of the first regions to be affected by AD pathology in humans, the observation that the EC is susceptible to differential bioenergetic regulation in response to a metabolic stressor such as\n                    <jats:italic>APOE4<\/jats:italic>\n                    may point to a causative factor in the pathogenesis of AD.\n                  <\/jats:p>","DOI":"10.1038\/s41598-020-61142-8","type":"journal-article","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T07:02:46Z","timestamp":1583737366000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["APOE4 is Associated with Differential Regional Vulnerability to Bioenergetic Deficits in Aged APOE Mice"],"prefix":"10.1038","volume":"10","author":[{"given":"Estela","family":"Area-Gomez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delfina","family":"Larrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Pera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi R.","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Guilfoyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Pirhaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Shannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirra A.","family":"Arain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Ashok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allissa A.","family":"Dillman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen Y.","family":"Figueroa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1058-3831","authenticated-orcid":false,"given":"Mark R.","family":"Cookson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven S.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9249-8181","authenticated-orcid":false,"given":"Ernest","family":"Fraenkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen E.","family":"Duff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5252-8048","authenticated-orcid":false,"given":"Tal","family":"Nuriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,9]]},"reference":[{"key":"61142_CR1","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1146\/annurev.genom.1.1.507","volume":"1","author":"RW Mahley","year":"2000","unstructured":"Mahley, R. W. & Rall, S. C. Jr. Apolipoprotein E: far more than a lipid transport protein. Annu. Rev. Genomics Hum. Genet. 1, 507\u2013537 (2000).","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"61142_CR2","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1007\/s00018-004-4009-z","volume":"61","author":"X Han","year":"2004","unstructured":"Han, X. The role of apolipoprotein E in lipid metabolism in the central nervous system. Cell Mol. Life Sci. 61, 1896\u20131906 (2004).","journal-title":"Cell Mol. Life Sci."},{"key":"61142_CR3","first-page":"a006312","volume":"2","author":"DM Holtzman","year":"2012","unstructured":"Holtzman, D. M., Herz, J. & Bu, G. Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. Cold Spring Harb. Perspect. Med. 2, a006312 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"61142_CR4","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"CC Liu","year":"2013","unstructured":"Liu, C. C., Kanekiyo, T., Xu, H. & Bu, G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat. Rev. Neurol. 9, 106\u2013118 (2013).","journal-title":"Nat. Rev. Neurol."},{"key":"61142_CR5","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer, L. A. et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278, 1349\u20131356 (1997).","journal-title":"JAMA"},{"key":"61142_CR6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1159\/000017120","volume":"10","author":"DC Rubinsztein","year":"1999","unstructured":"Rubinsztein, D. C. & Easton, D. F. Apolipoprotein E genetic variation and Alzheimer\u2019s disease. a meta-analysis. Dement. Geriatr. Cogn. Disord. 10, 199\u2013209 (1999).","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"61142_CR7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/ng1197-263","volume":"17","author":"KR Bales","year":"1997","unstructured":"Bales, K. R. et al. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat. Genet. 17, 263\u2013264 (1997).","journal-title":"Nat. Genet."},{"issue":"Pt 2","key":"61142_CR8","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1042\/bj3060599","volume":"306","author":"EM Castano","year":"1995","unstructured":"Castano, E. M. et al. Fibrillogenesis in Alzheimer\u2019s disease of amyloid beta peptides and apolipoprotein E. Biochem. J. 306(Pt 2), 599\u2013604 (1995).","journal-title":"Biochem. J."},{"key":"61142_CR9","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/0896-6273(93)90070-8","volume":"11","author":"GW Rebeck","year":"1993","unstructured":"Rebeck, G. W., Reiter, J. S., Strickland, D. K. & Hyman, B. T. Apolipoprotein E in sporadic Alzheimer\u2019s disease: allelic variation and receptor interactions. Neuron 11, 575\u2013580 (1993).","journal-title":"Neuron"},{"key":"61142_CR10","doi-asserted-by":"publisher","first-page":"9649","DOI":"10.1073\/pnas.90.20.9649","volume":"90","author":"DE Schmechel","year":"1993","unstructured":"Schmechel, D. E. et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl Acad. Sci. U S Am. 90, 9649\u20139653 (1993).","journal-title":"Proc. Natl Acad. Sci. U S Am."},{"key":"61142_CR11","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/372092a0","volume":"372","author":"J Ma","year":"1994","unstructured":"Ma, J., Yee, A., Brewer, H. B. Jr., Das, S. & Potter, H. Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nat. 372, 92\u201394 (1994).","journal-title":"Nat."},{"key":"61142_CR12","doi-asserted-by":"publisher","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","volume":"3","author":"JM Castellano","year":"2011","unstructured":"Castellano, J. M. et al. Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance. Sci. Transl. Med. 3, 89ra57 (2011).","journal-title":"Sci. Transl. Med."},{"key":"61142_CR13","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1073\/pnas.050004797","volume":"97","author":"DM Holtzman","year":"2000","unstructured":"Holtzman, D. M. et al. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer\u2019s disease. Proc. Natl Acad. Sci. U S Am. 97, 2892\u20132897 (2000).","journal-title":"Proc. Natl Acad. Sci. U S Am."},{"key":"61142_CR14","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.molmed.2010.04.004","volume":"16","author":"Y Huang","year":"2010","unstructured":"Huang, Y. Abeta-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer\u2019s disease. Trends Mol. Med. 16, 287\u2013294 (2010).","journal-title":"Trends Mol. Med."},{"key":"61142_CR15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/alzrt204","volume":"5","author":"AB Wolf","year":"2013","unstructured":"Wolf, A. B. et al. Apolipoprotein E as a beta-amyloid-independent factor in alzheimer\u2019s disease. Alzheimers Res. Ther. 5, 38 (2013).","journal-title":"Alzheimers Res. Ther."},{"key":"61142_CR16","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1056\/NEJM199603213341202","volume":"334","author":"EM Reiman","year":"1996","unstructured":"Reiman, E. M. et al. Preclinical evidence of Alzheimer\u2019s disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N. Engl. J. Med. 334, 752\u2013758 (1996).","journal-title":"N. Engl. J. Med."},{"key":"61142_CR17","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1073\/pnas.2635903100","volume":"101","author":"EM Reiman","year":"2004","unstructured":"Reiman, E. M. et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer\u2019s dementia. Proc. Natl Acad. Sci. U S Am. 101, 284\u2013289 (2004).","journal-title":"Proc. Natl Acad. Sci. U S Am."},{"key":"61142_CR18","doi-asserted-by":"publisher","first-page":"8299","DOI":"10.1073\/pnas.0500579102","volume":"102","author":"EM Reiman","year":"2005","unstructured":"Reiman, E. M. et al. Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism. Proc. Natl Acad. Sci. U S Am. 102, 8299\u20138302 (2005).","journal-title":"Proc. Natl Acad. Sci. U S Am."},{"key":"61142_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/srep03754","volume":"4","author":"QR Ong","year":"2014","unstructured":"Ong, Q. R., Chan, E. S., Lim, M. L., Cole, G. M. & Wong, B. S. Reduced phosphorylation of brain insulin receptor substrate and Akt proteins in apolipoprotein-E4 targeted replacement mice. Sci. Rep. 4, 3754 (2014).","journal-title":"Sci. Rep."},{"key":"61142_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neuron.2017.09.003","volume":"96","author":"N Zhao","year":"2017","unstructured":"Zhao, N. et al. Apolipoprotein E4 Impairs Neuronal Insulin Signaling by Trapping Insulin Receptor in the Endosomes. Neuron 96, 115\u2013129 e115 (2017).","journal-title":"Neuron"},{"key":"61142_CR21","doi-asserted-by":"crossref","unstructured":"Johnson, L. A. et al. Apolipoprotein E4 mediates insulin resistance-associated cerebrovascular dysfunction and the post-prandial response. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism, 271678X17746186 (2017).","DOI":"10.1177\/0271678X17746186"},{"key":"61142_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/srep43701","volume":"7","author":"LA Johnson","year":"2017","unstructured":"Johnson, L. A., Torres, E. R., Impey, S., Stevens, J. F. & Raber, J. Apolipoprotein E4 and Insulin Resistance Interact to Impair Cognition and Alter the Epigenome and Metabolome. Sci. Rep. 7, 43701 (2017).","journal-title":"Sci. Rep."},{"key":"61142_CR23","first-page":"411","volume":"48","author":"JT Keeney","year":"2015","unstructured":"Keeney, J. T., Ibrahimi, S. & Zhao, L. Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female. Brain: Evid. Mechanism Neuroprotection ApoE2 Implic. Alzheimer\u2019s Dis. Prev. Early Intervention. J. Alzheimer\u2019s disease: JAD. 48, 411\u2013424 (2015).","journal-title":"Brain: Evid. Mechanism Neuroprotection ApoE2 Implic. Alzheimer\u2019s Dis. Prev. Early Intervention. J. Alzheimer\u2019s disease: JAD."},{"key":"61142_CR24","doi-asserted-by":"publisher","first-page":"6665","DOI":"10.1523\/JNEUROSCI.2262-17.2018","volume":"38","author":"L Wu","year":"2018","unstructured":"Wu, L., Zhang, X. & Zhao, L. Human ApoE Isoforms Differentially Modulate Brain Glucose and Ketone Body Metabolism: Implications for Alzheimer\u2019s Disease Risk Reduction and Early Intervention. J. neuroscience: Off. J. Soc. Neurosci. 38, 6665\u20136681 (2018).","journal-title":"J. neuroscience: Off. J. Soc. Neurosci."},{"key":"61142_CR25","doi-asserted-by":"publisher","first-page":"18694","DOI":"10.1073\/pnas.0508254102","volume":"102","author":"S Chang","year":"2005","unstructured":"Chang, S. et al. Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity. Proc. Natl Acad. Sci. U S Am. 102, 18694\u201318699 (2005).","journal-title":"Proc. Natl Acad. Sci. U S Am."},{"key":"61142_CR26","doi-asserted-by":"publisher","first-page":"8838","DOI":"10.1073\/pnas.151254698","volume":"98","author":"Y Huang","year":"2001","unstructured":"Huang, Y. et al. Apolipoprotein E fragments present in Alzheimer\u2019s disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons. Proc. Natl Acad. Sci. U S Am. 98, 8838\u20138843 (2001).","journal-title":"Proc. Natl Acad. Sci. U S Am."},{"key":"61142_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1750-1326-4-35","volume":"4","author":"T Nakamura","year":"2009","unstructured":"Nakamura, T., Watanabe, A., Fujino, T., Hosono, T. & Michikawa, M. Apolipoprotein E4 (1-272) fragment is associated with mitochondrial proteins and affects mitochondrial function in neuronal cells. Mol. Neurodegener. 4, 35 (2009).","journal-title":"Mol. Neurodegener."},{"key":"61142_CR28","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.neuroscience.2003.10.011","volume":"124","author":"PM Sullivan","year":"2004","unstructured":"Sullivan, P. M., Mace, B. E., Maeda, N. & Schmechel, D. E. Marked regional differences of brain human apolipoprotein E expression in targeted replacement mice. Neurosci. 124, 725\u2013733 (2004).","journal-title":"Neurosci."},{"key":"61142_CR29","doi-asserted-by":"publisher","first-page":"17972","DOI":"10.1074\/jbc.272.29.17972","volume":"272","author":"PM Sullivan","year":"1997","unstructured":"Sullivan, P. M. et al. Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J. Biol. Chem. 272, 17972\u201317980 (1997).","journal-title":"J. Biol. Chem."},{"key":"61142_CR30","doi-asserted-by":"publisher","first-page":"702","DOI":"10.3389\/fnins.2017.00702","volume":"11","author":"T Nuriel","year":"2017","unstructured":"Nuriel, T. et al. The Endosomal-Lysosomal Pathway Is Dysregulated by APOE4 Expression in Vivo. Front. Neurosci. 11, 702 (2017).","journal-title":"Front. Neurosci."},{"key":"61142_CR31","doi-asserted-by":"publisher","first-page":"e21746","DOI":"10.1371\/journal.pone.0021746","volume":"6","author":"GW Rogers","year":"2011","unstructured":"Rogers, G. W. et al. High throughput microplate respiratory measurements using minimal quantities of isolated mitochondria. PLoS One 6, e21746 (2011).","journal-title":"PLoS One"},{"key":"61142_CR32","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1042\/BJ20110162","volume":"435","author":"MD Brand","year":"2011","unstructured":"Brand, M. D. & Nicholls, D. G. Assessing mitochondrial dysfunction in cells. Biochem. J. 435, 297\u2013312 (2011).","journal-title":"Biochem. J."},{"key":"61142_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01444-0","volume":"8","author":"T Nuriel","year":"2017","unstructured":"Nuriel, T. et al. Neuronal hyperactivity due to loss of inhibitory tone in APOE4 mice lacking Alzheimer\u2019s disease-like pathology. Nat. Commun. 8, 1464 (2017).","journal-title":"Nat. Commun."},{"key":"61142_CR34","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/nmeth.3940","volume":"13","author":"L Pirhaji","year":"2016","unstructured":"Pirhaji, L. et al. Revealing disease-associated pathways by network integration of untargeted metabolomics. Nat. methods 13, 770\u2013776 (2016).","journal-title":"Nat. methods"},{"key":"61142_CR35","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1152\/physrev.1980.60.1.143","volume":"60","author":"AM Robinson","year":"1980","unstructured":"Robinson, A. M. & Williamson, D. H. Physiological roles of ketone bodies as substrates and signals in mammalian tissues. Physiological Rev. 60, 143\u2013187 (1980).","journal-title":"Physiological Rev."},{"key":"61142_CR36","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1038\/jcbfm.2013.87","volume":"33","author":"Y Zhang","year":"2013","unstructured":"Zhang, Y. et al. Ketosis proportionately spares glucose utilization in brain. J. Cereb. blood flow. metabolism: Off. J. Int. Soc. Cereb. Blood Flow. Metab. 33, 1307\u20131311 (2013).","journal-title":"J. Cereb. blood flow. metabolism: Off. J. Int. Soc. Cereb. Blood Flow. Metab."},{"key":"61142_CR37","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1016\/j.neurobiolaging.2015.03.012","volume":"36","author":"AL Lin","year":"2015","unstructured":"Lin, A. L., Zhang, W., Gao, X. & Watts, L. Caloric restriction increases ketone bodies metabolism and preserves blood flow in aging brain. Neurobiol. aging 36, 2296\u20132303 (2015).","journal-title":"Neurobiol. aging"},{"key":"61142_CR38","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1096\/fj.201500182","volume":"30","author":"J Thevenet","year":"2016","unstructured":"Thevenet, J. et al. Medium-chain fatty acids inhibit mitochondrial metabolism in astrocytes promoting astrocyte-neuron lactate and ketone body shuttle systems. FASEB journal: Off. Publ. Federation Am. Societies Exp. Biol. 30, 1913\u20131926 (2016).","journal-title":"FASEB journal: Off. Publ. Federation Am. Societies Exp. Biol."},{"key":"61142_CR39","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1111\/j.1471-4159.1991.tb11435.x","volume":"56","author":"N Auestad","year":"1991","unstructured":"Auestad, N., Korsak, R. A., Morrow, J. W. & Edmond, J. Fatty acid oxidation and ketogenesis by astrocytes in primary culture. J. neurochemistry 56, 1376\u20131386 (1991).","journal-title":"J. neurochemistry"},{"key":"61142_CR40","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.plefa.2003.05.001","volume":"70","author":"M Guzman","year":"2004","unstructured":"Guzman, M. & Blazquez, C. Ketone body synthesis in the brain: possible neuroprotective effects. Prostaglandins, leukotrienes, Essent. Fat. acids 70, 287\u2013292 (2004).","journal-title":"Prostaglandins, leukotrienes, Essent. Fat. acids"},{"key":"61142_CR41","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1046\/j.1471-4159.1995.65062450.x","volume":"65","author":"MG Bixel","year":"1995","unstructured":"Bixel, M. G. & Hamprecht, B. Generation of ketone bodies from leucine by cultured astroglial cells. J. neurochemistry 65, 2450\u20132461 (1995).","journal-title":"J. neurochemistry"},{"key":"61142_CR42","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11064-007-9444-4","volume":"33","author":"R Murin","year":"2008","unstructured":"Murin, R. & Hamprecht, B. Metabolic and regulatory roles of leucine in neural cells. Neurochem. Res. 33, 279\u2013284 (2008).","journal-title":"Neurochem. Res."},{"key":"61142_CR43","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/978-1-4939-2377-9_13","volume":"1277","author":"AH Emwas","year":"2015","unstructured":"Emwas, A. H. The strengths and weaknesses of NMR spectroscopy and mass spectrometry with particular focus on metabolomics research. Methods Mol. Biol. 1277, 161\u2013193 (2015).","journal-title":"Methods Mol. Biol."},{"key":"61142_CR44","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/0003-2697(87)90483-0","volume":"161","author":"SP Bessman","year":"1987","unstructured":"Bessman, S. P. The creatine phosphate energy shuttle\u2013the molecular asymmetry of a \u201cpool\u201d. Anal. Biochem. 161, 519\u2013523 (1987).","journal-title":"Anal. Biochem."},{"key":"61142_CR45","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/mrm.1910380408","volume":"38","author":"W Chen","year":"1997","unstructured":"Chen, W., Zhu, X. H., Adriany, G. & Ugurbil, K. Increase of creatine kinase activity in the visual cortex of human brain during visual stimulation: a 31P magnetization transfer study. Magnetic Reson. Med. 38, 551\u2013557 (1997).","journal-title":"Magnetic Reson. Med."},{"key":"61142_CR46","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3389\/fendo.2013.00102","volume":"4","author":"A Schousboe","year":"2013","unstructured":"Schousboe, A., Bak, L. K. & Waagepetersen, H. S. Astrocytic Control of Biosynthesis and Turnover of the Neurotransmitters Glutamate and GABA. Front. Endocrinol. 4, 102 (2013).","journal-title":"Front. Endocrinol."},{"key":"61142_CR47","doi-asserted-by":"crossref","unstructured":"Kreft, M., Bak, L. K., Waagepetersen, H. S. & Schousboe, A. Aspects of astrocyte energy metabolism, amino acid neurotransmitter homoeostasis and metabolic compartmentation. ASN neuro 4 (2012).","DOI":"10.1042\/AN20120007"},{"key":"61142_CR48","doi-asserted-by":"publisher","first-page":"25959","DOI":"10.3390\/ijms161125939","volume":"16","author":"A Falkowska","year":"2015","unstructured":"Falkowska, A. et al. Energy Metabolism of the Brain, Including the Cooperation between Astrocytes and Neurons, Especially in the Context of Glycogen Metabolism. Int. J. Mol. Sci. 16, 25959\u201325981 (2015).","journal-title":"Int. J. Mol. Sci."},{"key":"61142_CR49","doi-asserted-by":"publisher","first-page":"5588","DOI":"10.1073\/pnas.0501703102","volume":"102","author":"AB Patel","year":"2005","unstructured":"Patel, A. B. et al. The contribution of GABA to glutamate\/glutamine cycling and energy metabolism in the rat cortex in vivo. Proc. Natl Acad. Sci. USA 102, 5588\u20135593 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"61142_CR50","doi-asserted-by":"crossref","first-page":"33426","DOI":"10.1074\/jbc.274.47.33426","volume":"274","author":"R Rossignol","year":"1999","unstructured":"Rossignol, R., Malgat, M., Mazat, J. P. & Letellier, T. Threshold effect and tissue specificity. Implic. mitochondrial cytopathies. J. Biol. Chem. 274, 33426\u201333432 (1999).","journal-title":"Implic. mitochondrial cytopathies. J. Biol. Chem."},{"key":"61142_CR51","doi-asserted-by":"publisher","first-page":"e25823","DOI":"10.1371\/journal.pone.0025823","volume":"6","author":"AM Celotto","year":"2011","unstructured":"Celotto, A. M., Chiu, W. K., Van Voorhies, W. & Palladino, M. J. Modes of metabolic compensation during mitochondrial disease using the Drosophila model of ATP6 dysfunction. PLoS One 6, e25823 (2011).","journal-title":"PLoS One"},{"key":"61142_CR52","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.cell.2006.06.010","volume":"125","author":"DC Chan","year":"2006","unstructured":"Chan, D. C. Mitochondria: dynamic organelles in disease, aging, and development. Cell 125, 1241\u20131252 (2006).","journal-title":"Cell"},{"key":"61142_CR53","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.cbi.2010.12.002","volume":"191","author":"BE Sansbury","year":"2011","unstructured":"Sansbury, B. E., Jones, S. P., Riggs, D. W., Darley-Usmar, V. M. & Hill, B. G. Bioenergetic function in cardiovascular cells: the importance of the reserve capacity and its biological regulation. Chemico-biological Interact. 191, 288\u2013295 (2011).","journal-title":"Chemico-biological Interact."},{"key":"61142_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.202","volume":"6","author":"J Pfleger","year":"2015","unstructured":"Pfleger, J., He, M. & Abdellatif, M. Mitochondrial complex II is a source of the reserve respiratory capacity that is regulated by metabolic sensors and promotes cell survival. Cell Death Dis. 6, e1835 (2015).","journal-title":"Cell Death Dis."},{"key":"61142_CR55","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.cmet.2017.04.015","volume":"25","author":"BH Goodpaster","year":"2017","unstructured":"Goodpaster, B. H. & Sparks, L. M. Metabolic Flexibility in Health and Disease. Cell Metab. 25, 1027\u20131036 (2017).","journal-title":"Cell Metab."},{"key":"61142_CR56","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.mam.2012.05.005","volume":"34","author":"F Palmieri","year":"2013","unstructured":"Palmieri, F. The mitochondrial transporter family SLC25: identification, properties and physiopathology. Mol. Asp. Med. 34, 465\u2013484 (2013).","journal-title":"Mol. Asp. Med."},{"key":"61142_CR57","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S0022-2828(08)80056-9","volume":"27","author":"VA Saks","year":"1995","unstructured":"Saks, V. A. et al. Control of cellular respiration in vivo by mitochondrial outer membrane and by creatine kinase. A new speculative hypothesis: possible involvement of mitochondrial-cytoskeleton interactions. J. Mol. Cell. cardiology 27, 625\u2013645 (1995).","journal-title":"J. Mol. Cell. cardiology"},{"key":"61142_CR58","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.bbabio.2010.01.004","volume":"1797","author":"I Bratic","year":"2010","unstructured":"Bratic, I. & Trifunovic, A. Mitochondrial energy metabolism and ageing. Biochimica et. biophysica acta 1797, 961\u2013967 (2010).","journal-title":"Biochimica et. biophysica acta"},{"key":"61142_CR59","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/j.1471-4159.2004.02516.x","volume":"90","author":"S Vesce","year":"2004","unstructured":"Vesce, S., Kirk, L. & Nicholls, D. G. Relationships between superoxide levels and delayed calcium deregulation in cultured cerebellar granule cells exposed continuously to glutamate. J. neurochemistry 90, 683\u2013693 (2004).","journal-title":"J. neurochemistry"},{"key":"61142_CR60","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0014-5793(97)01159-9","volume":"416","author":"SS Korshunov","year":"1997","unstructured":"Korshunov, S. S., Skulachev, V. P. & Starkov, A. A. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett. 416, 15\u201318 (1997).","journal-title":"FEBS Lett."},{"key":"61142_CR61","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1038\/jcbfm.2013.128","volume":"33","author":"P Schonfeld","year":"2013","unstructured":"Schonfeld, P. & Reiser, G. Why does brain metabolism not favor burning of fatty acids to provide energy? Reflections on disadvantages of the use of free fatty acids as fuel for brain. J. Cereb. Blood Flow. Metab. 33, 1493\u20131499 (2013).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"61142_CR62","doi-asserted-by":"publisher","first-page":"27255","DOI":"10.1074\/jbc.M112.374629","volume":"287","author":"CL Quinlan","year":"2012","unstructured":"Quinlan, C. L. et al. Mitochondrial complex II can generate reactive oxygen species at high rates in both the forward and reverse reactions. J. Biol. Chem. 287, 27255\u201327264 (2012).","journal-title":"J. Biol. Chem."},{"key":"61142_CR63","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/ana.25142","volume":"83","author":"JL Whitwell","year":"2018","unstructured":"Whitwell, J. L. et al. [(18) F]AV-1451 clustering of entorhinal and cortical uptake in Alzheimer\u2019s disease. Ann. Neurol. 83, 248\u2013257 (2018).","journal-title":"Ann. Neurol."},{"key":"61142_CR64","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13195-018-0403-x","volume":"10","author":"N Mattsson","year":"2018","unstructured":"Mattsson, N. et al. Greater tau load and reduced cortical thickness in APOE epsilon4-negative Alzheimer\u2019s disease: a cohort study. Alzheimers Res. Ther. 10, 77 (2018).","journal-title":"Alzheimers Res. Ther."},{"key":"61142_CR65","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1212\/WNL.53.8.1825","volume":"53","author":"C Geroldi","year":"1999","unstructured":"Geroldi, C. et al. APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD. Neurol. 53, 1825\u20131832 (1999).","journal-title":"Neurol."},{"key":"61142_CR66","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1136\/jnnp.65.3.322","volume":"65","author":"K Juottonen","year":"1998","unstructured":"Juottonen, K., Lehtovirta, M., Helisalmi, S., Riekkinen, P. J. Sr. & Soininen, H. Major decrease in the volume of the entorhinal cortex in patients with Alzheimer\u2019s disease carrying the apolipoprotein E epsilon4 allele. J. neurology, neurosurgery, psychiatry 65, 322\u2013327 (1998).","journal-title":"J. neurology, neurosurgery, psychiatry"},{"key":"61142_CR67","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/S1474-4422(07)70106-0","volume":"6","author":"P Shaw","year":"2007","unstructured":"Shaw, P. et al. Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study. Lancet Neurol. 6, 494\u2013500 (2007).","journal-title":"Lancet Neurol."},{"key":"61142_CR68","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.neuroimage.2008.03.039","volume":"41","author":"AC Burggren","year":"2008","unstructured":"Burggren, A. C. et al. Reduced cortical thickness in hippocampal subregions among cognitively normal apolipoprotein E e4 carriers. Neuroimage 41, 1177\u20131183 (2008).","journal-title":"Neuroimage"},{"key":"61142_CR69","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1126\/science.aac8128","volume":"350","author":"L Kunz","year":"2015","unstructured":"Kunz, L. et al. Reduced grid-cell-like representations in adults at genetic risk for Alzheimer\u2019s disease. Sci. 350, 430\u2013433 (2015).","journal-title":"Sci."},{"key":"61142_CR70","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13195-017-0250-1","volume":"9","author":"HN Yassine","year":"2017","unstructured":"Yassine, H. N. et al. DHA brain uptake and APOE4 status: a PET study with [1-(11)C]-DHA. Alzheimers Res. Ther. 9, 23 (2017).","journal-title":"Alzheimers Res. Ther."},{"key":"61142_CR71","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.plefa.2007.10.016","volume":"77","author":"JT Brenna","year":"2007","unstructured":"Brenna, J. T. & Diau, G. Y. The influence of dietary docosahexaenoic acid and arachidonic acid on central nervous system polyunsaturated fatty acid composition. Prostaglandins Leukot. Essent. Fat. Acids 77, 247\u2013250 (2007).","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"61142_CR72","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1083\/jcb.201803152","volume":"217","author":"G Yellen","year":"2018","unstructured":"Yellen, G. Fueling thought: Management of glycolysis and oxidative phosphorylation in neuronal metabolism. J. Cell Biol. 217, 2235\u20132246 (2018).","journal-title":"J. Cell Biol."},{"key":"61142_CR73","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/35036213","volume":"1","author":"H Eichenbaum","year":"2000","unstructured":"Eichenbaum, H. A cortical-hippocampal system for declarative memory. Nat. reviews. Neurosci. 1, 41\u201350 (2000).","journal-title":"Nat. reviews. Neurosci."},{"key":"61142_CR74","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0896-6273(00)00018-0","volume":"27","author":"LM Frank","year":"2000","unstructured":"Frank, L. M., Brown, E. N. & Wilson, M. Trajectory encoding in the hippocampus and entorhinal cortex. Neuron 27, 169\u2013178 (2000).","journal-title":"Neuron"},{"key":"61142_CR75","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nature01171","volume":"420","author":"AV Egorov","year":"2002","unstructured":"Egorov, A. V., Hamam, B. N., Fransen, E., Hasselmo, M. E. & Alonso, A. A. Graded persistent activity in entorhinal cortex neurons. Nat. 420, 173\u2013178 (2002).","journal-title":"Nat."},{"key":"61142_CR76","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239\u2013259 (1991).","journal-title":"Acta Neuropathol."},{"key":"61142_CR77","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.15252\/embj.201796797","volume":"36","author":"M Pera","year":"2017","unstructured":"Pera, M. et al. Increased localization of APP-C99 in mitochondria-associated ER membranes causes mitochondrial dysfunction in Alzheimer disease. EMBO J. 36, 3356\u20133371 (2017).","journal-title":"EMBO J."},{"key":"61142_CR78","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1194\/jlr.D700041-JLR200","volume":"49","author":"V Matyash","year":"2008","unstructured":"Matyash, V., Liebisch, G., Kurzchalia, T. V., Shevchenko, A. & Schwudke, D. Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J. Lipid Res. 49, 1137\u20131146 (2008).","journal-title":"J. Lipid Res."},{"key":"61142_CR79","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1365-313X.2011.04682.x","volume":"68","author":"P Giavalisco","year":"2011","unstructured":"Giavalisco, P. et al. Elemental formula annotation of polar and lipophilic metabolites using (13) C, (15) N and (34) S isotope labelling, in combination with high-resolution mass spectrometry. Plant. J. 68, 364\u2013376 (2011).","journal-title":"Plant. J."},{"key":"61142_CR80","doi-asserted-by":"publisher","first-page":"e37149","DOI":"10.1371\/journal.pone.0037149","volume":"7","author":"Q Chen","year":"2012","unstructured":"Chen, Q. et al. Untargeted plasma metabolite profiling reveals the broad systemic consequences of xanthine oxidoreductase inactivation in mice. PLoS One 7, e37149 (2012).","journal-title":"PLoS One"},{"key":"61142_CR81","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1002\/nbm.3629","volume":"29","author":"MH Baslow","year":"2016","unstructured":"Baslow, M. H. et al. Stimulation-induced transient changes in neuronal activity, blood flow and N-acetylaspartate content in rat prefrontal cortex: a chemogenetic fMRS-BOLD study. NMR Biomed. 29, 1678\u20131687 (2016).","journal-title":"NMR Biomed."},{"key":"61142_CR82","doi-asserted-by":"publisher","first-page":"5099","DOI":"10.1523\/JNEUROSCI.5338-13.2014","volume":"34","author":"G Kaur","year":"2014","unstructured":"Kaur, G. et al. Glutamatergic transmission aberration: a major cause of behavioral deficits in a murine model of Down\u2019s syndrome. J. neuroscience: Off. J. Soc. Neurosci. 34, 5099\u20135106 (2014).","journal-title":"J. neuroscience: Off. J. Soc. Neurosci."},{"key":"61142_CR83","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1002\/mrm.26615","volume":"78","author":"JJ Miller","year":"2017","unstructured":"Miller, J. J., Cochlin, L., Clarke, K. & Tyler, D. J. Weighted averaging in spectroscopic studies improves statistical power. Magnetic Reson. Med. 78, 2082\u20132094 (2017).","journal-title":"Magnetic Reson. Med."},{"key":"61142_CR84","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/mrm.1910300604","volume":"30","author":"SW Provencher","year":"1993","unstructured":"Provencher, S. W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magnetic Reson. Med. 30, 672\u2013679 (1993).","journal-title":"Magnetic Reson. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61142-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61142-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61142-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T03:03:26Z","timestamp":1670295806000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61142-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,9]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["61142"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-61142-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/482422","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,9]]},"assertion":[{"value":"22 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.E.D is on the board of directors of Ceracuity LLC. The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4277"}}